3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Osteosarcoma
4
Leukemia
4
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Down Syndrome
3
Rhabdoid Tumor
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Myeloid, Accelerated Phase
2
Head and Neck Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Blast Crisis
2
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Shwachman-Diamond Syndrome
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Multiple Myeloma
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Methotrexate
×
90 days
×
Clear all
No trials found.